Desq Long
Sign in

Company

BridgeBio Oncology Therapeutics, Inc.

BBOT · CIK 0001869105

SEC FORM 4
$4,125.18

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Disposition (code F) of 1,047 shares at $3.94 per share.

Reporting Person Ben Yong · Officer Title Chief Med & Dev Officer · Transaction Code F

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001193125-26-414123 · filed 2026-10-05 · View filing →

SEC FORM 4
$4,125.18

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Disposition (code F) of 1,047 shares at $3.94 per share.

Reporting Person Beltran Pedro · Officer Title President and CEO · Transaction Code F

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001193125-26-414127 · filed 2026-10-05 · View filing →

SEC FORM 4
$1,351.42

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Disposition (code F) of 343 shares at $3.94 per share.

Reporting Person Elmelech Idan · Officer Title COO & Principal Financial Ofcr · Transaction Code F

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001193125-26-414131 · filed 2026-10-05 · View filing →

SEC FORM 4
$496.44

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Disposition (code F) of 126 shares at $3.94 per share.

Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code F

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001193125-26-414135 · filed 2026-10-05 · View filing →

SEC FORM 4
$0.00

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Acquisition (code A) of 9,038 shares at $0 per share.

Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code A

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-390624 · filed 2026-09-14 · View filing →

SEC FORM 4
$1,120.56

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Disposition (code F) of 203 shares at $5.52 per share.

Reporting Person Cobo Marc · Officer Title Principal Accounting Officer · Transaction Code F

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-390624 · filed 2026-09-14 · View filing →